Navigation Links
SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production
Date:4/22/2009

nufactured materials. SAFC has four focus areas - SAFC Pharma(TM), SAFC Supply Solutions(R), SAFC Biosciences(R) and SAFC Hitech(TM) - and had annual sales of $624 million in 2008. SAFC is one of the world's top 10 fine chemical companies. For more information about SAFC, visit www.safcglobal.com.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its chemical and biochemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 countries and has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.

Cautionary Statement: This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Companies' expectations, goals, beliefs, intentions and the like, which involve assumptions regarding the Companies' operations and conditions in the markets the Companies serve. The Companies do not undertake any obligation to update these forward-looking statements.

SAFC(R), SAFC Biosciences(R), SAFC Supply Solutions(R), SAFC Hi
'/>"/>

SOURCE Sigma-Aldrich Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
2. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
3. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
4. DuPont and USDA ARS to Collaborate on New E. coli Test in Beef
5. DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects
6. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
7. The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial
8. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
9. Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic
10. febit and TGen Collaborate to Study New DNA Capture Method
11. Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., LOVELAND, Colo., Nov. 19 /PRNewswire-FirstCall/ ...ustomers, experience, Heska Corporation (Nasdaq: ...the launch of its new and improved website. The u...alysis, design and programming to align the site w...jectives. ,, (Logo: http://www.newscom.com/c...
(Date:11/19/2009)...MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswire-FirstCa... ) announced today that its corporate presentation... Jaffray Health Care Conference on Wednesday, Dece...ntation will be webcast from The New York Palace H.... King, Alexza President and CEO. ,, To acces...
(Date:11/19/2009)... ABBOTT PARK, Ill., Nov. 19 /PRNewswire-FirstCall/...: ABT ) as one of its Most Admired Corporate Dea...l honored Abbott as its Most Admired Dealmaker in...se of acquisitions and divestitures since January ...ped its business portfolio with a focus on high-gr...
Breaking Medicine Technology:Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance 57885 1Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance 57885 2Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance 57885 3Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance 57885 4Experimental approach may reverse rheumatoid arthritis and osteoporosis 57883 1Experimental approach may reverse rheumatoid arthritis and osteoporosis 57883 2Experimental approach may reverse rheumatoid arthritis and osteoporosis 57883 3Cancer predisposition from genetic variation shows strong gender bias 57881 1Cancer predisposition from genetic variation shows strong gender bias 57881 2
...ntial target in inflammatory indicat..., April 15 Roche announced today that it,will acq... focusing on,therapeutics targeting PI3-kinase (PI...ant role in disease progression and in resistance ... studies have demonstrated,the activity of PI3-K i...
...(Amex: CXM ) and its operating unit InnerCool The... a preclinical study, demonstrating a new and,expa... for the potential,treatment of acute myocardial i...e by BioMed Central (BMC) Cardiovascular Disorders...w.newscom.com/cgi-bin/prnh/20080415/LATU038 ), (L...
Other Medicine Technology:Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 2Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 3Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 4Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 2Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 3Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 4Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 5Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 6Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 7Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 8Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 9Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 10Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 11Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 12
(Date:11/21/2009)...ber 21, 2009 Test Test T...est Test Test Test Test Test Test,Test Test Test T...est Test,Test Test Test Test Test Test Test Test T...More test More test More test More test More test,...More test More test More,test More test , , Pl...
(Date:11/21/2009)...ew Haven Dental Group merges their practice with t..., (PRWEB) November 21, 200...ners Dr. David Gibson, Dr. Dean Cloutier, Dr. John...d their growing practice with that of esteemed col... decided he wanted to retire from dentistry in ord...
(Date:11/20/2009)... Nov. 20 The United Sta...e to make essential changes its health reform bill... funding and conscience protection on abortion, pr...lude strong provisions for adequate affordability....ill an "enormous disappointment" that creates new ...
(Date:11/20/2009)...v. 20 Centene Corporat...esent at the Bank of America Merrill Lynch 2009 Cr... the Crowne Plaza Hotel Times Square in New York C...r 2nd at 8:30 a.m. Eastern Time. Investors and oth...cast of Centene,s presentation at: http://www.ver...
(Date:11/20/2009)...line November 20 in the Journal of the National C...nd hopes that often appear in news coverage of can...both the media and journals to help alleviate the ...ven Woloshin, M.D., M.S., of Center for Medicine a... Policy and Clinical Practice in New Hampshire, an...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...Eliminating fax orders and associated manual proce...ey for suppliers and their customers , , MISSISSA...ovidien Canada has selected GHX,s G-Fax(TM) fax co...rs to electronic data interchange (EDI) or other e...
...Application to Help Improve Hospital Efficiency , ...today introduced HealthSpace Advisor, a Web-based ...e how effectively they use space in key revenue ge...venue and improving healthcare delivery. , , The...
...LONG BEACH, Calif. and SAN FRANCISCO, Jan. 29 The...lth Technology Center (HealthTech) to establish th...ancing the use of technologies that dramatically e... boomers," said Bruce Chernof, M.D., president and...
...CHICAGO, Jan. 29 The American Dietetic Associatio...trition professionals, is calling for procedural r... to make the government,s most authoritative sourc...eral food and nutrition education programs. , , ...
...PARK CITY, Utah, Jan. 29 Nutraceutical Internation...sults for the fiscal 2009 first quarter ended Dece...t quarter were $39.6 million compared to $41.1 mil...pared to net income of $3.2 million, or $0.28 dilu...
...NIH is Part of Growing List of Federal Agencies th...Notification , , NEW YORK, Jan. 29 SWN Communi...tification and other on-demand alerting and respon...ization. The NIH will extend its use of the SWN A...
Other Medicine News:Health News:Covidien Canada Streamlines Integration and Processing of Fax-based Orders With GHX G-Fax(TM) Fax Conversion Service 2Health News:Covidien Canada Streamlines Integration and Processing of Fax-based Orders With GHX G-Fax(TM) Fax Conversion Service 3Health News:CSC Introduces HealthSpace Advisor Benchmarking Tool 2Health News:CSC Introduces HealthSpace Advisor Benchmarking Tool 3Health News:The SCAN Foundation Grants $5 Million to the Health Technology Center to Establish National Center for Technology and Aging 2Health News:The SCAN Foundation Grants $5 Million to the Health Technology Center to Establish National Center for Technology and Aging 3Health News:American Dietetic Association Calls for Accountability in Dietary Guidelines for Americans to Make Them More Effective 2Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 2Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 3Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 4Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 5Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 6Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 7Health News:National Institutes of Health Expands Use of Emergency Notification Services Provided by Send Word Now(TM) Across NIH Campus 2Health News:National Institutes of Health Expands Use of Emergency Notification Services Provided by Send Word Now(TM) Across NIH Campus 3
... practice management software for practices requir...actice management software system includes schedul...mation, encounter preparation, claims development,...electronic claims remittance, system reports, Repo...
A.I.med's medical billing software
HCS INTERACTANT Application Financial System Solutions
Infinity Amylase CNPG3 (Liquid)
Medicine Products: